Status:

COMPLETED

Immunologic Predisposition of HIV Patients to Develop Methicillin-Resistant Staphylococcus Aureus (MRSA) Colonization and Infection

Lead Sponsor:

Henry M. Jackson Foundation for the Advancement of Military Medicine

Collaborating Sponsors:

Infectious Diseases Clinical Research Program

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions:

HIV Infections

Staphylococcal Infections

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to investigate the role of T helper 17 cells (Th17) in the pathogenesis of MRSA infections.

Eligibility Criteria

Inclusion

  • All participant inclusion criteria:
  • Greater or equal to 18 years of age
  • Willingness to undergo blood draw. Skin biopsy will be requested, but is optional
  • AND-
  • HIV-positive and MRSA-negative Group:
  • Documented positive HIV test result
  • Negative colonization swabs for S. aureus within 14 days of enrollment
  • No evidence of skin/soft tissue infection
  • HIV-positive and MRSA-Colonization Group:
  • Documented positive HIV test result
  • History of of colonization with MRSA w/in 14 days of study enrollment
  • HIV-positive and MRSA Infection Group:
  • Documented positive HIV test result
  • Skin/soft tissue infection with a positive wound culture showing MRSA within 7 days of enrollment
  • MRSA infection is not associated with an intravenous catheter or other nosocomial procedure
  • HIV Negative groups:
  • Same criteria used for the HIV-negative groups as listed above.
  • No history of HIV infection.
  • Willing to undergo an HIV blood test, which must have a negative result.
  • Exclusion Criteria:
  • Women with positive urine pregnancy test within 7 days of study enrollment
  • Women who are within 6 months of being postpartum or who are currently breastfeeding
  • Subjects unable or unwilling to complete questionnaires and blood draw.

Exclusion

    Key Trial Info

    Start Date :

    March 1 2009

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    August 26 2016

    Estimated Enrollment :

    52 Patients enrolled

    Trial Details

    Trial ID

    NCT00859677

    Start Date

    March 1 2009

    End Date

    August 26 2016

    Last Update

    February 15 2023

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Naval Medical Center San Diego

    San Diego, California, United States, 92134

    2

    Walter Reed National Military Medical Center

    Bethesda, Maryland, United States, 20889